DAFNA Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

DAFNA Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-978,463	Closed	-$21M	–	89
2026 Q1	$21M	Sell	978,463 -20,700	-2%	-$292K	4.77%	4
2025 Q4	$9.31M	Hold	999,163	–	–	2.16%	13
2025 Q3	$7.04M	Buy	999,163 +120,000	+14%	+$826K	1.74%	14
2025 Q2	$5.71M	Buy	879,163 +147,800	+20%	+$1.02M	1.58%	16
2025 Q1	$5.8M	Hold	731,363	–	–	1.64%	16
2024 Q4	$9.27M	Sell	731,363 -19,000	-3%	-$264K	2.36%	14
2024 Q3	$10.5M	Buy	750,363 +83,900	+13%	+$1.2M	2.47%	13
2024 Q2	$9.18M	Hold	666,463	–	–	2.19%	16
2024 Q1	$11M	Sell	666,463 -20,000	-3%	-$299K	2.51%	12
2023 Q4	$10M	Buy	686,463 +100,000	+17%	+$1.21M	2.4%	13
2023 Q3	$7.2M	Buy	586,463 +79,363	+16%	+$1.04M	2.24%	13
2023 Q2	$6.05M	Buy	+507,100	New	+$6.62M	1.66%	19

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

DAFNA Capital Management's DAWN Position: Q2 2026 in Review

DAFNA Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 978,463 shares — an estimated $21M sold.

DAFNA Capital Management first reported a position in DAWN in Q2 2023 and held it in 12 quarters. The position peaked at $21M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

DAFNA Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
DAFNA Capital Management sold 978,463 Day One Biopharmaceuticals shares in Q2 2026, an estimated $21M.
DAFNA Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2023 and held it in 12 quarters.
DAFNA Capital Management's Day One Biopharmaceuticals position peaked at $21M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.